Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Preview: Neumora Therapeutics, Inc Set To IPO Tomorrow

Neumora Therapeutics, Inc (NASDAQ:NMRA) IPO will take place September, 15 on the NASDAQ exchange under the ticker NMRA.…
byBenzinga Insights
September 14, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Neumora Therapeutics, Inc (NASDAQ:NMRA) IPO will take place September, 15 on the NASDAQ exchange under the ticker NMRA.

The company is offering shares at an expected price between $16.00 and $18.00 per share with an insider lock-up period of 180 days ending on March 13, 2024.

See also: Benzinga IPO Calendar

About Neumora Therapeutics, Inc

Neumora Therapeutics, Inc is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed.

See also: Benzinga’s Most Shorted Stocks

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Reported Late Monday March 27, YanGuFang International Group Co., Ltd. Announces Pricing Of Initial Public Offering Of 2M Ordinary Shares At A Price Of $4/Share; Expected To Commence Trading On March 28, 2023 Under The Ticker Symbol “YGF”

By Happy Mohamed
March 28, 1:11 AM
YanGuFang International Group Co., Ltd. (the "Company"), a healthy food company primarily engaging in the production, research and development, and sales of oat and grain products, today announced the pricing

YGF

Read More

GM-Backed Self-Driving Company Momenta Readies For US IPO Launch: Report

By Shivani Kumaresan
May 6, 6:46 AM
Auto giant General Motors-backed Beijing Momenta Technology Co., a Chinese self-driving firm, has quietly filed for a potential IPO in the U.S., report says. Momenta reportedly aims to raise $200-$300 million through share sales, with discussions ongoing. The move underscores Momenta's rapid growth and signifies a significant step in its global expansion strategy.

GM